David M. Zellmer

Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents

Sagar Agarwal, Rajendar K. Mittapalli, David M. Zellmer et al. · Molecular Cancer Therapeutics · 2012 · 92 citations · Full text

Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy

Adam J. Litterman, David M. Zellmer, Karen L. Grinnen et al. · The Journal of Immunology · 2013 · 66 citations · Full text

Immunology, Immunoediting, Cd4 T Cell Responses +18

Immunotoxin targeting CD133+ breast carcinoma cells

John R. Ohlfest, David M. Zellmer, Jayanth Panyam et al. · Drug Delivery and Translational Research · 2012 · 39 citations

Breast Oncology, Immunology, Breast Cancer +3

Superior Efficacy of Tumor Cell Vaccines Grown in Physiologic Oxygen

Michael R. Olin, Brian M. Andersen, David M. Zellmer et al. · Clinical Cancer Research · 2010 · 32 citations · Full text

Identification and characterization of a novel scFv recognizing human and mouse CD133

Suresh Kumar Swaminathan, Lin Niu, Nate N. Waldron et al. · Drug Delivery and Translational Research · 2012 · 18 citations · Full text

Image Analysis, Mouse Cd133, Engineering +8